Go to contents
Go to menu
°Ë»ö¾î ÀÔ·Â
Ȩ
·Î±×ÀÎ
Áñ°Üã±âÃß°¡
ENGLlSH
°í±Þ°Ë»ö
Àú³Îº°°Ë»ö
¿ø¹®Á¦°ø Àú³Îº°°Ë»ö
¿¬±¸ºÐ¾ßº° °Ë»ö
ÇÐȸ/Çùȸ Á¤º¸
Àú³Î Á¤º¸
Àú³Î Åõ°í ±ÔÁ¤
KMbase ¼Ò°³
°øÁö»çÇ×
¾÷µ¥ÀÌÆ® Á¤º¸
³» Á¤º¸
ÀúÀå ³í¹®
°ü½ÉºÐ¾ß ³í¹®
°ü½ÉÇÐȸ/ÇмúÁ¤º¸
¿ø¹®½Åû
°ü½ÉºÐ¾ß °ü¸®
½ºÅ©¸³Æ® ȯ°æ¿¡¼ Áö¿øµË´Ï´Ù.
³í¹®°Ë»ö
°í±Þ°Ë»ö
Àú³Îº°°Ë»ö
¿ø¹®Á¦°ø Àú³Î°Ë»ö
¿¬±¸ºÐ¾ßº° °Ë»ö
SITE LINK
PubMed
Google Scholar
KoreaScience
NDSL
KoreaMed
RISS
MEDLIS
Cross Check
´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö
( Journal of the Korean Society for Therapeutic Radiology and Oncology )
: °Ë»ö°á°ú :
9
  
°Ë»ö°á°ú¸ðµÎ¼±ÅÃ
1
°í¿¡³ÊÁö ¹æ»ç¼±Ä¡·áÀÇ Á¤µµ°ü¸®¸¦ À§ÇÑ Fiduciary Plate ¹× Orientation MarkerÀÇ °³¹ß
New Fiduciary Plate and Orientation Marker for High Energy Radiation Therapy
¿ìÈ«±Õ/Wu HG
Çã¼ø³ç/±èÇÐÀç
´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö
2004³â 22±Ç 1È£ 69 ~ 75
2
°í°¨µµ Çü±¤ÆÇÀ» ÀÌ¿ëÇÑ ½Ç½Ã°£ ¼±·®ÃøÁ¤ °¡´É¼º ¿¬±¸
Feasibility Study of the Real-Time IMRT Dosimetry Using a Scintillation Screen
ÀÓ»ó¿í/Lim SW
À̺´¿ë/°í¿µÀº/Áö¿µÈÆ/±èÁ¾ÈÆ/¾È½Âµµ/ÀÌ»ó¿í/½Å¼º¼ö/±Ç¼öÀÏ/ÃÖÀº°æ
´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö
2004³â 22±Ç 1È£ 64 ~ 68
3
Àü»êÈ´ÜÃþÃÔ¿µ ÁÖ»ç½Ã°£(Scan Time)ÀÌ ÆóÁ¾¾ç¿îµ¿ÀÇ ÀçÇö¼º¿¡ ¹ÌÄ¡´Â ¿µÇ⠺м®
Impact of the Planning CT Scan Time on the Reflection of the Lung Tumor Motion
±è¼ö»ê/Kim SS
ÇϼºÈ¯/ÃÖÀº°æ/À̺´¿ë
´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö
2004³â 22±Ç 1È£ 55 ~ 63
4
¹æ»ç¼± Á¶»ç ÈÄ ¹ß»ýÇÑ ÈòÁã ½ÉÀå¼Õ»ó¿¡¼ CaptoprilÀÇ ¹æ¾î¿ªÇÒ°ú ±âÀü
The Radioprotective Effect and Mechanism of Captopril on Radiation Induced-Heart Damage in Rats
Àå½ÂÈñ/Chang SH
ÀÌ°æÀÚ/±¸Çý¼ö
´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö
2004³â 22±Ç 1È£ 40 ~ 54
5
»ï¼º¼¿ïº´¿ø ¹æ»ç¼±Á¾¾çÇаú Á¾¾çµî·Ï Á¤º¸ÀÇ Å¸´çµµ Æò°¡
Evaluation of Tumor Registry Validity in Samsung Medical Center Radiation Oncology Department
¹Ú¿ø/Park W
Çã½ÂÀç/±è´ë¿ë/½Å¼º¼ö/¾È¿ëÂù/ÀÓµµÈÆ/±è¼±¿ì
´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö
2004³â 22±Ç 1È£ 33 ~ 39
6
½Äµµ¾Ï¿¡¼ µ¿½Ã Ç×¾ÏÈÇйæ»ç¼±¿ä¹ý°ú °ü³»±ÙÁ¢Ä¡·áÀÇ °á°ú-»ýÁ¸À²À» Áß½ÉÀ¸·Î ÇÑ ÈÄÇâÀû ºÐ¼®
Results of Concurrent Chemoradiotherapy and Intraluminal Brachytherapy in Esophageal Carcinoma -Retr
...
³²ÅñÙ/Nam TK
³ªº´½Ä/Á¤¿õ±â/¾È¼ºÀÚ/¼ÛÁÖ¿µ
´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö
2004³â 22±Ç 1È£ 25 ~ 32
7
À¯¹æÀýÁ¦¼úÀ» ½ÃÇàÇÑ À¯¹æ¾Ï ȯÀÚ¿¡¼ ¹æ»ç¼±°ú Ç×¾ÏÁ¦ Ä¡·á¼ºÀû
Postmastectomy Radiotherapy and Chemotherapy in Patients with Breast Cancer
¾È¼ºÀÚ/Ahn SJ
Á¤¿õ±â/³²ÅñÙ/³ªº´½Ä/¼ÛÁÖ¿µ/¹Ú½ÂÁø
´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö
2004³â 22±Ç 1È£ 17 ~ 24
8
À¯¹æ °ü»óÇdz»¾ÏÀÇ À¯¹æ º¸Á¸¼ú ÈÄ ¹æ»ç¼± Ä¡·áÀÇ ¼ºÀû°ú ¿¹ÈÄ ÀÎÀÚ ºÐ¼®
Treatment Outcome and Analysis of the Prognostic Factors of Ductal Carcinoma in situ Treated with Br
...
±è°æÁÖ/Kim KJ
Çã½ÂÀç/¹Ú ¿ø/¾çÁ¤Çö/³²¼®Áø/±èÁ¤ÇÑ/À̼º°ø/ÀÌÁöÇö/¼º¼ö/ÀÌÁ¤Àº/°¹Î±Ô/¹Ú¿µÁ¦/³²Èñ¸²
´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö
2004³â 22±Ç 1È£ 11 ~ 16
9
¼ö¼ú ºÒ°¡´ÉÇÑ ±¹¼Ò ÁøÇà ºñ¼Ò¼¼Æ÷¼º Æó¾ÏÀÇ ÁýÇÕÀû ¿ä¹ý
Multidisciplinary Management of the Locally Advanced Unresectable Non-Small Cell Lung Cancer
Á¶°üÈ£ ( Cho Kwan Ho )
´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö
2004³â 22±Ç 1È£ 1 ~ 10